Cape Investment Advisory’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30
Closed -$2.41K 237
2025
Q4
$2.41K Buy
+30
New +$2.51K ﹤0.01% 1068
2025
Q3
Sell
-35
Closed -$2.44K 855
2025
Q2
$2.44K Hold
35
﹤0.01% 907
2025
Q1
$1.74K Sell
35
-20
-36% -$1.26K ﹤0.01% 908
2024
Q4
$3.84K Buy
55
+10
+22% +$830 ﹤0.01% 795
2024
Q3
$4.72K Sell
45
-20
-31% -$2.34K ﹤0.01% 714
2024
Q2
$9.24K Buy
+65
New +$7.49K ﹤0.01% 538

Other funds holding ACLS

Cape Investment Advisory's ACLS Position: Q1 2026 in Review

Cape Investment Advisory sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 30 shares — an estimated $2.41K sold.

Cape Investment Advisory first reported a position in ACLS in Q2 2024 and held it in 6 quarters. The position peaked at $9.24K in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Cape Investment Advisory reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Cape Investment Advisory sold 30 Axcelis shares in Q1 2026, an estimated $2.41K.
  • Cape Investment Advisory first reported a position in Axcelis in Q2 2024 and held it in 6 quarters.
  • Cape Investment Advisory's Axcelis position peaked at $9.24K in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Cape Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.